UK Expert Advises FDA on Hydrocodone Policy

In January, an advisory panel of the Food and Drug Administration recommended tighter controls and greater scrutiny be placed on hydrocodone, one of the most widely abused pain medications in the United States, by reclassifying it from Schedule III to the more restrictive Schedule II. Sharon Walsh, director of the University of Kentuckys Center on Drug and Alcohol Research, gave expert testimony at the meeting that led to the up-scheduling recommendation.
Source: UK College of Medicine News - Category: Universities & Medical Training Tags: 7H000 clinical Source Type: news